tetrandrine has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, SS; Hagino, N; Kobayashi, S; Liang, XC; Tsutsumi, T | 1 |
| Fukuta, M; Inaba, K; Kimura, I; Kimura, M; Kobayashi, S; Kontani, H; Mita, S; Niwa, M | 1 |
2 other study(ies) available for tetrandrine and Diabetic Retinopathy
| Article | Year |
|---|---|
Therapeutic efficacy of Stephania tetrandra S. Moore for treatment of neovascularization of retinal capillary (retinopathy) in diabetes--in vitro study.
Topics: Alkaloids; Animals; Benzylisoquinolines; Capillaries; Diabetes Mellitus, Experimental; Diabetic Retinopathy; In Vitro Techniques; Male; Neovascularization, Pathologic; Phytotherapy; Rats; Rats, Sprague-Dawley; Stephania tetrandra; Streptozocin | 2002 |
Inhibitory effects of tetrandrine and related synthetic compounds on angiogenesis in streptozotocin-diabetic rodents.
Topics: Alkaloids; Animals; Becaplermin; Benzylisoquinolines; Blood; Cells, Cultured; Culture Techniques; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Drugs, Chinese Herbal; Endothelial Growth Factors; Endothelium, Vascular; Lymphokines; Male; Mice; Neovascularization, Pathologic; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Streptozocin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |